These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 15670148

  • 1. Various secretory phospholipase A2 enzymes are expressed in rheumatoid arthritis and augment prostaglandin production in cultured synovial cells.
    Masuda S, Murakami M, Komiyama K, Ishihara M, Ishikawa Y, Ishii T, Kudo I.
    FEBS J; 2005 Feb; 272(3):655-72. PubMed ID: 15670148
    [Abstract] [Full Text] [Related]

  • 2. Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes.
    Bidgood MJ, Jamal OS, Cunningham AM, Brooks PM, Scott KF.
    J Immunol; 2000 Sep 01; 165(5):2790-7. PubMed ID: 10946311
    [Abstract] [Full Text] [Related]

  • 3. Expression of secretory phospholipase A2 enzymes in lungs of humans with pneumonia and their potential prostaglandin-synthetic function in human lung-derived cells.
    Masuda S, Murakami M, Mitsuishi M, Komiyama K, Ishikawa Y, Ishii T, Kudo I.
    Biochem J; 2005 Apr 01; 387(Pt 1):27-38. PubMed ID: 15509193
    [Abstract] [Full Text] [Related]

  • 4. Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues.
    Masuda S, Murakami M, Ishikawa Y, Ishii T, Kudo I.
    Biochim Biophys Acta; 2005 Oct 01; 1736(3):200-10. PubMed ID: 16188494
    [Abstract] [Full Text] [Related]

  • 5. Increased expression of human type IIa secretory phospholipase A2 antigen in arthritic synovium.
    Jamal OS, Conaghan PG, Cunningham AM, Brooks PM, Munro VF, Scott KF.
    Ann Rheum Dis; 1998 Sep 01; 57(9):550-8. PubMed ID: 9849315
    [Abstract] [Full Text] [Related]

  • 6. Secretory low-molecular-weight phospholipases A2 and their specific receptor in bile ducts of patients with intrahepatic calculi: factors of chronic proliferative cholangitis.
    Shoda J, Kano M, Asano T, Irimura T, Ueda T, Iwasaki R, Furukawa M, Kamiya J, Nimura Y, Todoroki T, Matsuzaki Y, Tanaka N.
    Hepatology; 1999 Apr 01; 29(4):1026-36. PubMed ID: 10094942
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-1 beta induces cytosolic phospholipase A2 and prostaglandin H synthase in rheumatoid synovial fibroblasts. Evidence for their roles in the production of prostaglandin E2.
    Hulkower KI, Wertheimer SJ, Levin W, Coffey JW, Anderson CM, Chen T, DeWitt DL, Crowl RM, Hope WC, Morgan DW.
    Arthritis Rheum; 1994 May 01; 37(5):653-61. PubMed ID: 8185692
    [Abstract] [Full Text] [Related]

  • 8. The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2.
    Murakami M, Shimbara S, Kambe T, Kuwata H, Winstead MV, Tischfield JA, Kudo I.
    J Biol Chem; 1998 Jun 05; 273(23):14411-23. PubMed ID: 9603953
    [Abstract] [Full Text] [Related]

  • 9. Suppressive effect of secretory phospholipase A2 inhibitory peptide on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts, and its antiarthritic activity in hTNFtg mice.
    Thwin MM, Douni E, Arjunan P, Kollias G, Kumar PV, Gopalakrishnakone P.
    Arthritis Res Ther; 2009 Jun 05; 11(5):R138. PubMed ID: 19765281
    [Abstract] [Full Text] [Related]

  • 10. Potentiation of tumor necrosis factor alpha-induced secreted phospholipase A2 (sPLA2)-IIA expression in mesangial cells by an autocrine loop involving sPLA2 and peroxisome proliferator-activated receptor alpha activation.
    Beck S, Lambeau G, Scholz-Pedretti K, Gelb MH, Janssen MJ, Edwards SH, Wilton DC, Pfeilschifter J, Kaszkin M.
    J Biol Chem; 2003 Aug 08; 278(32):29799-812. PubMed ID: 12782627
    [Abstract] [Full Text] [Related]

  • 11. Induction of release of secretory nonpancreatic phospholipase A2 from human articular chondrocytes.
    Pruzanski W, Bogoch E, Katz A, Wloch M, Stefanski E, Grouix B, Sakotic G, Vadas P.
    J Rheumatol; 1995 Nov 08; 22(11):2114-9. PubMed ID: 8596153
    [Abstract] [Full Text] [Related]

  • 12. Group IID, IIE, IIF and III secreted phospholipase A2s.
    Murakami M, Miki Y, Sato H, Murase R, Taketomi Y, Yamamoto K.
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Jun 08; 1864(6):803-818. PubMed ID: 30905347
    [Abstract] [Full Text] [Related]

  • 13. Phospholipase A2 in chamber angle of normal eyes and patients with primary open angle glaucoma and exfoliation glaucoma.
    Rönkkö S, Rekonen P, Kaarniranta K, Puustjarvi T, Teräsvirta M, Uusitalo H.
    Mol Vis; 2007 Mar 26; 13():408-17. PubMed ID: 17417602
    [Abstract] [Full Text] [Related]

  • 14. Redundant and segregated functions of granule-associated heparin-binding group II subfamily of secretory phospholipases A2 in the regulation of degranulation and prostaglandin D2 synthesis in mast cells.
    Enomoto A, Murakami M, Valentin E, Lambeau G, Gelb MH, Kudo I.
    J Immunol; 2000 Oct 01; 165(7):4007-14. PubMed ID: 11034411
    [Abstract] [Full Text] [Related]

  • 15. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.
    Pap T, Franz JK, Hummel KM, Jeisy E, Gay R, Gay S.
    Arthritis Res; 2000 Oct 01; 2(1):59-64. PubMed ID: 11219390
    [Abstract] [Full Text] [Related]

  • 16. Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor.
    Morioka Y, Saiga A, Yokota Y, Suzuki N, Ikeda M, Ono T, Nakano K, Fujii N, Ishizaki J, Arita H, Hanasaki K.
    Arch Biochem Biophys; 2000 Sep 01; 381(1):31-42. PubMed ID: 11019817
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Presence of secretory group IIa and V phospholipase A2 and cytosolic group IValpha phospholipase A2 in chondrocytes from patients with rheumatoid arthritis.
    Leistad L, Feuerherm AJ, Ostensen M, Faxvaag A, Johansen B.
    Clin Chem Lab Med; 2004 Sep 01; 42(6):602-10. PubMed ID: 15259375
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Discrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritis.
    Schedel J, Distler O, Woenckhaus M, Gay RE, Simmen B, Michel BA, Müller-Ladner U, Gay S.
    Ann Rheum Dis; 2004 Oct 01; 63(10):1205-11. PubMed ID: 15361372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.